Literature DB >> 21717590

Maximizing the yield of lymph node cytology: Lessons learned from rapid onsite evaluation of image- and endoscopic-guided biopsies of hilar and mediastinal lymph nodes.

Gilda da Cunha Santos1, Scott L Boerner, William R Geddie.   

Abstract

The evaluation of mediastinal and hilar lymph nodes for tissue diagnosis and staging of lung cancer is now commonly performed by minimally invasive, nonsurgical procedures such as computed tomography-guided fine-needle aspiration and endobronchial ultrasound-guided transbronchial needle aspiration. Ensuring that a sufficient quantity of cellular material has been acquired to enable multiple studies has become a priority issue in the era of personalized medicine, especially for patients with lung cancer, and this can be accomplished by rapid onsite evaluation (ROSE). This commentary focuses on the use of ROSE in guided procedures, especially for hilar and mediastinal lymph node aspirates, and describes an algorithm for handling these specimens.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21717590     DOI: 10.1002/cncy.20166

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  4 in total

1.  Rapid on-site evaluation using telecytology: A major cancer center experience.

Authors:  Oscar Lin; Dorota Rudomina; Rusmir Feratovic; S Joseph Sirintrapun
Journal:  Diagn Cytopathol       Date:  2018-03-25       Impact factor: 1.582

2.  Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing.

Authors:  Luis E De Las Casas; David G Hicks
Journal:  Am J Clin Pathol       Date:  2021-05-18       Impact factor: 2.493

3.  EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples.

Authors:  Mauro Ajaj Saieg; William R Geddie; Scott L Boerner; Denis Bailey; Michael Crump; Gilda da Cunha Santos
Journal:  Cancer Cytopathol       Date:  2013-01-29       Impact factor: 5.284

4.  Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

Authors:  Elena F Brachtel; Theresa N Operaña; Peggy S Sullivan; Sarah E Kerr; Karen A Cherkis; Brock E Schroeder; Sarah M Dry; Catherine A Schnabel
Journal:  Oncotarget       Date:  2016-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.